Myriad Genetics Inc
XBER:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
XBER:MYD
|
US |
|
P
|
Park Hotels & Resorts Inc
F:HIP
|
US |
|
Talanx AG
LSE:0QA8
|
DE |
|
Curtiss-Wright Corp
NYSE:CW
|
US |
|
H
|
Healthcare Trust Of America Inc
F:HT01
|
US |
|
KB Financial Group Inc
KRX:105560
|
KR |
|
T
|
Trimble Inc
F:TB5
|
US |
|
Siemens Healthineers AG
F:SHL
|
DE |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
XHAM:BOY
|
ES |
|
DoubleVerify Holdings Inc
NYSE:DV
|
US |
|
Tesmec SpA
F:2GV
|
IT |
|
Toray Industries Inc
TSE:3402
|
JP |
|
Crane NXT Co
F:P8Q
|
US |
|
S
|
State Street Corp
F:ZYA
|
US |
|
Skyline Champion Corp
NYSE:SKY
|
US |
|
H
|
Heng Leasing and Capital PCL
SET:HENG
|
TH |
|
W
|
Westwing Group SE
XMUN:WEW
|
DE |
|
MacroGenics Inc
NASDAQ:MGNX
|
US |
|
S
|
Selective Insurance Group Inc
F:SV2
|
US |
|
U
|
UPM-Kymmene Oyj
XBER:RPL
|
FI |
|
P
|
Pitney Bowes Inc
DUS:PBW
|
US |
|
Healthcare Realty Trust Inc
F:HT0
|
US |
Wall St Price Targets
MYD Price Targets Summary
Myriad Genetics Inc
According to Wall Street analysts, the average 1-year price target for
MYD is 8.56 EUR with a low forecast of 5.45 EUR and a high forecast of 14.16 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MYD's stock price target?
Price Target
8.56
EUR
According to Wall Street analysts, the average 1-year price target for
MYD is 8.56 EUR with a low forecast of 5.45 EUR and a high forecast of 14.16 EUR.
What is the Revenue forecast for Myriad Genetics Inc?
Projected CAGR
6%
Over the last 4 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 6%.